Clearline Capital LP Biogen Inc. Transaction History
Clearline Capital LP
- $2.27 Billion
- Q3 2024
A detailed history of Clearline Capital LP transactions in Biogen Inc. stock. As of the latest transaction made, Clearline Capital LP holds 9,000 shares of BIIB stock, worth $1.25 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
9,000Holding current value
$1.25 Million% of portfolio
0.49%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BIIB
# of Institutions
996Shares Held
129MCall Options Held
1.37MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.32 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.22 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.01 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.02 Billion0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.93MShares$683 Million0.14% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $19.9B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...